Product Information
NISOLDIPINE ER 17 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $4.6590 per EA under NDC 00378209701. Its NADAC has been published 562 times since Nov 28, 2013.
Strength
17 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378209701
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
11/19/2025
Active Ingredients
NISOLDIPINEApproval Type
Generic (ANDA)
FDA Application
ANDA091001On Market Since
1/28/2011
Pharmacological Classes
Price Statistics
The NADAC for NISOLDIPINE ER 17 MG TABLET has been published 562 times since Nov 28, 2013, and over the history we have for it it has declined 5.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.6590 per EA |
|---|---|
| All-time high | $5.6818 (Apr 15, 2020) |
| All-time low | $3.3722 (Mar 19, 2025) |
| 52-week high | $4.7651 |
| 52-week low | $4.0218 |
| Median price | $4.9753 |
| Average price | $4.8950 |
| Largest weekly change | -29.5% (May 22, 2024) |
| Weeks tracked | 562 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the nisoldipine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NISOLDIPINE ER 17 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NISOLDIPINE ER 17 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $4.6590 per EA (NDC 00378209701), effective Apr 1, 2026.
How has the price of NISOLDIPINE ER 17 MG TABLET changed over time?
Over the history we have for it, the NADAC for NISOLDIPINE ER 17 MG TABLET has declined 5.3%. It has been tracked across 562 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NISOLDIPINE ER 17 MG TABLET?
Since Nov 28, 2013, the NADAC for NISOLDIPINE ER 17 MG TABLET has ranged from a low of $3.3722 (Mar 19, 2025) to a high of $5.6818 (Apr 15, 2020), with a median of $4.9753 per EA.
Are there cheaper alternatives to NISOLDIPINE ER 17 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NISOLDIPINE ER 17 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures NISOLDIPINE ER 17 MG TABLET?
NISOLDIPINE ER 17 MG TABLET (NDC 00378209701) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification